CoreWeave's IPO Valuation: $40 a Share, $19B

CoreWeave priced its March 2025 IPO at $40 per share, below the indicated range, for a valuation of around $19 billion. Here is how that figure was built and how to read the fully-diluted version.

Share
CoreWeave's IPO Valuation: $40 a Share, $19B

CoreWeave (Nasdaq: CRWV) priced its initial public offering at $40 per share on March 27, 2025, below the indicated $47 to $55 range, raising $1.5 billion and carrying a valuation reported at roughly $19 billion. That $19 billion figure is the one most outlets anchored to at pricing, though some reported closer to $23 billion on a fully-diluted basis, a distinction that matters.

Key takeaways

  • CoreWeave priced at $40 per share, under its own $47 to $55 range, and issued 37.5 million Class A shares to raise $1.5 billion.
  • The headline valuation at pricing was about $19 billion. Figures near $23 billion reflect a fully-diluted count that includes options, restricted stock and other convertible instruments, not just shares outstanding.
  • It was reported as the largest US tech IPO since 2021 (CNBC, 2025-03-27), which is why the decision to price below range drew attention.
  • As of October 1, 2026, CoreWeave's market capitalization was $48.85 billion, down about 31% over the prior twelve months.
  • CoreWeave is also the most widely tokenized of the recent listings tracked onchain, across four issuer and chain pairings. Those tokens are wrappers that track share prices. They are not the company's valuation and carry no shareholder rights.

How $40 produced a $19 billion number

An IPO valuation is arithmetic applied to a negotiated price. Multiply the offer price by the relevant share count and you get a company value. The gap between $19 billion and $23 billion comes entirely from which share count you use.

Basic shares outstanding counts the stock that exists at the moment of listing. Fully diluted adds everything that could reasonably convert into stock: employee options, restricted stock units, and similar instruments. Because CoreWeave, like most venture-backed companies, had granted a large pool of options and restricted stock before going public, the fully-diluted count is meaningfully larger than the basic count. Same price, bigger multiplier, bigger valuation.

Neither number is wrong. They answer different questions. The basic figure tells you what the tradeable stock was worth at the open. The fully-diluted figure tells you what the company is worth if every committed share eventually lands in the market. When you see two valuations for the same IPO, this is almost always the reason.

MetricValue at IPO
Offer price per share$40
Indicated range (set then missed)$47 to $55
Class A shares issued37.5 million
Gross proceeds raised$1.5 billion
Valuation (reported headline)~$19 billion
Valuation (fully diluted, some outlets)~$23 billion
Listing dateMarch 28, 2025

Why pricing below range matters

Before a company lists, its bankers run a roadshow, a series of pitches to large institutional investors, and publish an indicated price range. That range is a signal of expected demand. Pricing above it suggests the book of orders was oversubscribed. Pricing below it, as CoreWeave did, signals that demand came in softer than the range implied, and the deal was repriced to clear.

For the largest US tech offering since 2021, that was the story at listing: a marquee name that had to cut its price and shrink the deal to get it done. The valuation of roughly $19 billion was the result of that compromise, not the ambition the range had advertised.

If you want the mechanics of how a range becomes a final number, our walkthroughs on how LendingClub priced its 2014 IPO and the broader question of whether you can price an IPO before the IPO cover the same process on different deals.

Where the valuation sits now

A priced IPO is a snapshot, not a verdict. Once a stock trades, the market revalues it every second. As of October 1, 2026, CoreWeave's market capitalization stood at $48.85 billion, more than double the pricing valuation, but down roughly 31% over the preceding twelve months. For anyone reading an IPO headline: the pricing valuation tells you how the deal was struck, and nothing about where the company will trade a year later.

The tokenized CoreWeave, and why it is not the valuation

Separate from the Nasdaq-listed stock, several platforms issue tokenized wrappers, blockchain-based instruments that track the price of CoreWeave shares so they can be traded onchain around the clock. CoreWeave is the most widely tokenized of the 2025 to 2026 listings tracked onchain, spread across four issuer and chain pairings.

Two points matter for reading these. First, a wrapper's market value is not CoreWeave's valuation. It reflects how much of the wrapper exists onchain and what traders pay for it, nothing more. Second, holders of these tokens do not own CoreWeave equity, shareholder rights, or votes. The token references the share price. It does not confer ownership of the company.

What the onchain record does show is behavior. Over a recent 30-day window, one issuer's CoreWeave token (Backpack on Solana) turned over $25.7 million in transfers across 1,234 holders, while Robinhood's version moved $6.4 million across 20,079 holders. Robinhood's product had roughly sixteen times the holder count on a quarter of the volume. That split, a few large traders moving most of the money on one venue against many small holders on another, is the interesting observation, and it is invisible in the equity ticker.

To see that split at all, the same economic event has to resolve to the same fields across different issuers and chains: asset, issuer, sender, recipient, amount, USD value, and transfer type, so that a Backpack transfer on Solana and a Robinhood transfer are counted on the same basis instead of in incompatible formats. Allium normalizes those records across 150+ blockchains into shared schemas, which is what makes a cross-issuer comparison like the one above possible.

For a related read on how onchain markets price expectations around companies still in SEC registration, see our look at Anthropic versus OpenAI IPO odds on Polymarket.

Frequently asked questions

What was CoreWeave's IPO valuation?

CoreWeave priced its IPO at $40 per share on March 27, 2025, for a valuation reported at roughly $19 billion. Some outlets reported closer to $23 billion on a fully-diluted basis, which includes options and restricted stock beyond the basic shares outstanding.

Why did CoreWeave price below its range?

CoreWeave's indicated range was $47 to $55, but it priced at $40. Pricing below the range signals that demand from institutional investors came in softer than the roadshow range implied, so the deal was repriced to clear. It raised $1.5 billion on 37.5 million Class A shares.

What is CoreWeave worth now?

As of October 1, 2026, CoreWeave's market capitalization was $48.85 billion, more than double its pricing valuation but down about 31% over the prior twelve months. The pricing valuation describes how the deal was struck, not where the stock trades later.

Does buying a tokenized CoreWeave token mean I own CoreWeave stock?

No. Tokenized CoreWeave products are wrappers that track the share price so they can be traded onchain. Holders do not own company equity, shareholder rights, or voting rights, and the token's market value is not CoreWeave's valuation.

Why does CoreWeave have two different IPO valuations?

The difference comes from the share count used. The roughly $19 billion figure reflects basic shares outstanding at listing. The roughly $23 billion figure is fully diluted, adding options, restricted stock units, and similar convertible instruments. Same $40 price, larger multiplier.

How large was CoreWeave's IPO relative to other tech listings?

CoreWeave's $1.5 billion raise made it the largest US technology IPO since 2021, which is part of why its decision to price below the indicated range drew so much attention.


Interested in learning more about Allium’s tokenized securities data? Speak to someone on the team.


Allium provides onchain data infrastructure. Companies named in this article may be Allium customers, prospects or commercial counterparties. The authors and other Allium personnel may hold positions in the assets discussed. This article is informational only and is not investment, legal or tax advice. Data and information last reviewed: October 12, 2026.